BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1917624)

  • 1. Radiotherapy following radical prostatectomy in patients with adenocarcinoma of the prostate.
    Petrovich Z; Lieskovsky G; Langholz B; Luxton G; Jozsef G; Skinner DG
    Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):949-54. PubMed ID: 1917624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery with adjuvant irradiation in patients with pathologic stage C adenocarcinoma of the prostate.
    Petrovich Z; Lieskovsky G; Freeman J; Luxton G; Groshen S; Formenti S; Baert L; Chen SC; Skinner DG
    Cancer; 1995 Nov; 76(9):1621-8. PubMed ID: 8635067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical prostatectomy and postoperative irradiation in patients with pathological stage C (T3) carcinoma of the prostate.
    Petrovich Z; Lieskovsky G; Langholz B; Formenti S; Baert L; Streeter O; Skinner DG
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):139-47. PubMed ID: 9422570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of outcomes of radical prostatectomy with and without adjuvant pelvic irradiation in patients with pathologic stage C (T3N0) adenocarcinoma of the prostate.
    Petrovich Z; Lieskovsky G; Langholz B; Bochner B; Formenti S; Streeter O; Skinner DG
    Am J Clin Oncol; 1999 Aug; 22(4):323-31. PubMed ID: 10440184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjuvant radiotherapy following radical prostatectomy--results, acute and late toxicity].
    Wiegel T; Bressel M; Baumann M; Schwarz R; Hübener KH
    Strahlenther Onkol; 1993 Mar; 169(3):152-8. PubMed ID: 8465249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate.
    Perez CA; Michalski J; Brown KC; Lockett MA
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):573-84. PubMed ID: 8948341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule.
    Anscher MS; Prosnitz LR
    J Urol; 1987 Dec; 138(6):1407-12. PubMed ID: 3682068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative radiotherapy in 423 patients with pT3N0 prostate cancer.
    Petrovich Z; Lieskovsky G; Langholz B; Jozsef G; Streeter OE; Skinner DG
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):600-9. PubMed ID: 12062603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?
    Choo R; Hruby G; Hong J; Hong E; DeBoer G; Danjoux C; Morton G; Klotz L; Bhak E; Flavin A
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):674-80. PubMed ID: 11849789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients.
    Cozzarini C; Bolognesi A; Ceresoli GL; Fiorino C; Rossa A; Bertini R; Colombo R; Da Pozzo L; Montorsi F; Roscigno M; Calandrino R; Rigatti P; Villa E
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):674-83. PubMed ID: 15183470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation.
    Crane CH; Rich TA; Read PW; Sanfilippo NJ; Gillenwater JY; Kelly MD
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):681-6. PubMed ID: 9336150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years.
    Anscher MS; Clough R; Dodge R
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):369-75. PubMed ID: 10974449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update.
    Anscher MS; Robertson CN; Prosnitz R
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):37-43. PubMed ID: 7543893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
    Carrie C; Hasbini A; de Laroche G; Richaud P; Guerif S; Latorzeff I; Supiot S; Bosset M; Lagrange JL; Beckendorf V; Lesaunier F; Dubray B; Wagner JP; N'Guyen TD; Suchaud JP; Créhange G; Barbier N; Habibian M; Ferlay C; Fourneret P; Ruffion A; Dussart S
    Lancet Oncol; 2016 Jun; 17(6):747-756. PubMed ID: 27160475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical retropubic prostatectomy and postoperative adjuvant radiation for pathological stage C (PcN0) prostate cancer from 1976 to 1989: intermediate findings.
    Freeman JA; Lieskovsky G; Cook DW; Petrovich Z; Chen S; Groshen S; Skinner DG
    J Urol; 1993 May; 149(5):1029-34. PubMed ID: 8483203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of radical prostatectomy and adjuvant therapy in the management of locally advanced, clinical stage TC, prostate cancer.
    Yamada AH; Lieskovsky G; Petrovich Z; Chen SC; Groshen S; Skinner DG
    Am J Clin Oncol; 1994 Aug; 17(4):277-85. PubMed ID: 8048388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
    Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
    Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes?
    King CR; Presti JC; Gill H; Brooks J; Hancock SL
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):341-7. PubMed ID: 15145146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant radiotherapy following radical prostatectomy--results of 56 patients.
    Wiegel T; Bressel M; Carl UM
    Eur J Cancer; 1995; 31A(1):5-11. PubMed ID: 7535075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.